MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-13-2026
BioNano Genomics DPO Ratio 2011-2026 | BNGO
Annual DPO Ratio BioNano Genomics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 149 | 104 | 158 | 195 | 177 | 187 | 146 | 56.6 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 195 | 56.6 | 146 |
Quarterly DPO Ratio BioNano Genomics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 147 | 140 | 179 | 175 | - | 54.8 | 163 | 155 | - | 189 | 199 | 242 | - | 79.3 | 57.8 | 154 | - | 151 | 112 | 110 | - | 183 | 443 | 300 | 146 | 104 | 158 | 161 | 41.3 | 40.2 | 68 | 198 | 140 | 62.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 443 | 40.2 | 150 |
DPO Ratio of other stocks in the Diagnostics research industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Burning Rock Biotech Limited
BNR
|
125 | $ 17.35 | -6.52 % | $ 183 M |  China |
 |
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
4.24 K | $ 1.46 | -10.44 % | $ 1.94 M |  USA |
 |
Castle Biosciences
CSTL
|
65.8 | $ 19.26 | 1.99 % | $ 558 M | USA |
 |
Fulgent Genetics
FLGT
|
34.9 | $ 16.02 | -1.05 % | $ 484 M | USA |
 |
Agilent Technologies
A
|
50.1 | $ 112.14 | -0.98 % | $ 34.1 B | USA |
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
189 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
125 | - | -61.36 % | $ 2.46 M | USA |
 |
Illumina
ILMN
|
56.3 | $ 140.19 | -2.13 % | $ 22.3 B | USA |
 |
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M |  Britain |
 |
Interpace Biosciences
IDXG
|
33 | $ 1.8 | -5.26 % | $ 7.96 M | USA |
 |
CareDx, Inc
CDNA
|
44.2 | $ 20.04 | -2.22 % | $ 1.07 B | USA |
 |
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | USA |
 |
Lantheus Holdings
LNTH
|
23.6 | $ 94.57 | -2.18 % | $ 6.38 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | USA |
 |
Medpace Holdings
MEDP
|
13.3 | $ 420.05 | 0.21 % | $ 12.1 B | USA |
 |
Mettler-Toledo International
MTD
|
53.4 | $ 1 048.98 | 0.68 % | $ 21.6 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
45.9 | $ 3.62 | - | $ 335 M | USA |
 |
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M | China |
 |
NeoGenomics
NEO
|
19.7 | $ 8.3 | -0.72 % | $ 1.06 B | USA |
 |
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
24.5 | $ 158.51 | -0.5 % | $ 7.86 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | USA |
 |
National Research Corporation
NRC
|
10.1 | $ 19.0 | 0.37 % | $ 425 M | USA |
 |
Natera
NTRA
|
17.9 | $ 185.77 | -5.66 % | $ 18.3 B | USA |
 |
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
49.2 | - | - | $ 19.8 B | USA |
 |
Senseonics Holdings
SENS
|
68 | $ 5.84 | 0.34 % | $ 244 M | USA |
 |
Guardant Health
GH
|
48.6 | $ 95.26 | -3.45 % | $ 11.9 B | USA |
 |
Personalis
PSNL
|
65.7 | $ 6.46 | -3.73 % | $ 576 M | USA |
 |
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
6.52 | $ 118.21 | 0.96 % | $ 9.75 B |  Irlanda |
 |
Soleno Therapeutics
SLNO
|
1.44 K | $ 52.99 | -0.01 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
50 | - | - | $ 10.6 B |  Niderland |
 |
Twist Bioscience Corporation
TWST
|
12.5 | $ 49.69 | -6.16 % | $ 2.97 B | USA |
 |
Biomerica
BMRA
|
32.4 | $ 2.31 | -4.04 % | $ 5.31 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
31.5 | $ 251.84 | -0.89 % | $ 21 B | USA |
 |
Thermo Fisher Scientific
TMO
|
49.3 | $ 441.44 | -1.5 % | $ 166 B | USA |
 |
Trinity Biotech plc
TRIB
|
163 | $ 0.59 | 1.42 % | $ 212 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K |  Israel |
 |
Waters Corporation
WAT
|
102 | $ 332.1 | -0.33 % | $ 19.8 B | USA |
 |
Neogen Corporation
NEOG
|
62.7 | $ 8.36 | -0.83 % | $ 1.81 B | USA |